Yongjun Wang

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Venues

Nano letters

AAPS PharmSciTech

Science advances

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Hailong Kuang, Peipei Wang, Yuhang Wang, Jinbo Li, Jiang Yu, Lirui Jia, Shuo Li, Yan Ma, Hongzhuo Liu, Zhonggui He, Yongjun Wang
Liposomal Nanodrug Based on Norcantharidin Derivative for Increased in Vivo Activity. AAPS PharmSciTech 24 (5) (2023)
Hailong Kuang, Peipei Wang, Yuhang Wang, Jinbo Li, Jiang Yu, Lirui Jia, Shuo Li, Yan Ma, Hongzhuo Liu, Zhonggui He, Yongjun Wang
Liposomal Nanodrug Based on Norcantharidin Derivative for Increased in Vivo Activity. AAPS PharmSciTech 24 (5) (2023)
Zhaomeng Wang, Yanhua Liu, Shuo Li, Fanlin Meng, Jiang Yu, Shuang Zhou, Songtao Dong, Jianying Ye, Lingxiao Li, Chuang Zhang, Shengnan Qiu, Guimei Lin, Hongzhuo Liu, Shyh-Dar Li, Zhonggui He, Yongjun Wang
Bioinspired Nanocomplexes Comprising Phenolic Acid Derivative and Human Serum Albumin for Cancer Therapy. Nano letters (2022)
Zhaomeng Wang, Yanhua Liu, Shuo Li, Fanlin Meng, Jiang Yu, Shuang Zhou, Songtao Dong, Jianying Ye, Lingxiao Li, Chuang Zhang, Shengnan Qiu, Guimei Lin, Hongzhuo Liu, Shyh-Dar Li, Zhonggui He, Yongjun Wang
Bioinspired Nanocomplexes Comprising Phenolic Acid Derivative and Human Serum Albumin for Cancer Therapy. Nano letters 22 (24) (2022)
Zhaomeng Wang, Yanhua Liu, Shuo Li, Fanlin Meng, Jiang Yu, Shuang Zhou, Songtao Dong, Jianying Ye, Lingxiao Li, Chuang Zhang, Shengnan Qiu, Guimei Lin, Hongzhuo Liu, Shyh-Dar Li, Zhonggui He, Yongjun Wang
Bioinspired Nanocomplexes Comprising Phenolic Acid Derivative and Human Serum Albumin for Cancer Therapy. Nano letters 22 (24) (2022)
Zhaomeng Wang, Yanhua Liu, Shuo Li, Fanlin Meng, Jiang Yu, Shuang Zhou, Songtao Dong, Jianying Ye, Lingxiao Li, Chuang Zhang, Shengnan Qiu, Guimei Lin, Hongzhuo Liu, Shyh-Dar Li, Zhonggui He, Yongjun Wang
Bioinspired Nanocomplexes Comprising Phenolic Acid Derivative and Human Serum Albumin for Cancer Therapy. Nano letters 22 (24) (2022)
Yinxian Yang, Bingjun Sun, Shiyi Zuo, Ximu Li, Shuang Zhou, Lingxiao Li, Cong Luo, Hongzhuo Liu, Maosheng Cheng, Yongjun Wang, Shujun Wang, Zhonggui He, Jin Sun
Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity. Science advances 6 (45) (2020)
Jiang Yu, Shuang Zhou, Jinbo Li, Yingli Wang, Yujiao Su, Dongxu Chi, Jiamei Wang, Xue Wang, Zhonggui He, Guimei Lin, Dan Liu, Yongjun Wang
Simple weak-acid derivatives of paclitaxel for remote loading into liposomes and improved therapeutic effects. RSC advances 10 (46) (2020)
Bingjun Sun, Cong Luo, Xuanbo Zhang, Mengran Guo, Mengchi Sun, Han Yu, Qin Chen, Wenqian Yang, Menglin Wang, Shiyi Zuo, Pengyu Chen, Qiming Kan, Haotian Zhang, Yongjun Wang, Zhonggui He, Jin Sun
Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy. Nature communications 10 (1) (2019)

Yongjun Wang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yongjun Wang